AssayIndex

MKM-2512-N4579

Gonadorelin · 10 mg declared · Xi'an Mokemei Biotechnology Co., Ltd. · manufactured 01 Dec 2025

CHARACTERISED
Lot code
MKM-2512-N4579
Supplier
MKM — Xi'an Mokemei Biotechnology Co., Ltd.
Compound
Gonadorelin
Compound class
Hypothalamic and posterior-pituitary hormones
Declared label claim
10mg
Manufacture date
01 Dec 2025
Index quarter
2026-Q2
Independent assays
6
Laboratories involved
PeptideMeter, Medutest, Janoshik
Provenance mix
Buyer-sourced ×6
Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 6
Median purity 99.83% n=6
Spread (max − min) 0.55pp n=6
Standard deviation 0.201pp n=6
98.498.798.999.299.599.8100.0This lot (MKM-2512-N4579)This lot (MKM-2512-N4579): Q1 99.77, median 99.83, Q3 99.89, n=6outlier 99.38n=6All GonadorelinAll Gonadorelin: Q1 99.38, median 99.71, Q3 99.92, n=53outlier 98.49n=53 Purity (% area)
Figure 1. This lot's independent purity results against the whole Gonadorelin record set in the index. The vertical line is the index acceptance specification for the hypothalamic and posterior-pituitary hormones class, 98.5 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.
Section 2

Member reports 6

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-043052MKM-2512-N4579PeptideMeter2026-Q299.765.5993.1Buyer-sourced0PASS
AX-2026-043053MKM-2512-N4579PeptideMeter2026-Q299.795.37101.7Buyer-sourced0PASS
AX-2026-043054MKM-2512-N4579Medutest2026-Q299.935.7393.5Buyer-sourced0PASS
AX-2026-043055MKM-2512-N4579Medutest2026-Q299.876.4094.7Buyer-sourced0PASS
AX-2026-043056MKM-2512-N4579Medutest2026-Q299.385.4697.1Buyer-sourced0PASS
AX-2026-043057MKM-2512-N4579Janoshik2026-Q299.895.6397.8Buyer-sourced0PASS
Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

LaboratoryReportsPurity results (% area)MedianGradientPublished bias (pp)Bias-adjusted
PeptideMeter299.76, 99.7999.7828min-0.0599.83
Medutest399.93, 99.87, 99.3899.8725min+0.0899.79
Janoshik199.8999.8930min+0.0099.89

This lot contributes 3 paired comparisons to the inter-lab analysis.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

FigureSupplier COAThis reportIndex note
Purity (% area)99.5499.76divergence -0.29 pp vs batch median
Total impurities (% area)0.460.24
Largest single impurity (% area)0.270.14
Water (%)not stated5.59
Counter-ion (%)not stated4.51
Peptide content (%w/w)not stated89.36
Endotoxin (EU/mg)not statednot determined
Method stated on certificateYEScolumn, gradient and wavelength given
Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurityReported inMedian % areaRange
des-Gly10-NH2 (−74 Da)6 / 60.080.04–0.15
ring-opened pGlu (+18 Da)5 / 60.040.02–0.09
C-terminal free acid (+1 Da)4 / 60.020.01–0.05
oxidised Trp (+16 Da)3 / 60.140.03–0.35
Section 7

What this rollup does not establish